Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Aug 02, 2023

BUY
$1.09 - $2.09 $2,289 - $4,389
2,100 New
2,100 $3,000
Q2 2021

Jul 26, 2021

BUY
$12.25 - $18.61 $25,725 - $39,081
2,100 New
2,100 $30,000

Others Institutions Holding TALS

About Talaris Therapeutics, Inc.


  • Ticker TALS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,995,900
  • Market Cap $109M
  • Description
  • Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...
More about TALS
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.